![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by Rosy Crucifiction on November 28, 2009, at 12:04:53
For many, affecting neurotransmitters with antidepressants has had limited success, or results in only short term success with relapse. Clearly other physical systems can influence mood and may help relieve depression. Thyroid augmentation, for instance, has long been used as a depression treatment.
The link in women between estrogen levels and depression has been known, and therapeutically relevant, for some time. Men with frank hypogonadism (clearly subclinical serum and free testosterone levels) are known to have high rates of depression. This can be readily resolved with testosterone replacement therapy. Interestingly, testosterone increase dopamine levels.
In those with "normal" testosterone levels and TRD, it seems likely that testosterone replacement could offer an additional therapeutic option. Options include testosterone gels, implants, and injections as well as indirect boosting of testosterone levels with HCG and other compounds. There are few studies available, but anecdotal evidence among men receiving TRT is strong. Combining direct testosterone enhancement with HCG seems to have minimal long term effects on the HPTA axis.
Concerns about side effects include prostate enlargement and estrogenic side effects. Both sets of side effects can be readily addressed by supplements or, in more severe cases, well known and fairly benign medications.
Three relevant studies:
"Testosterone May Boost Efficacy Of Antidepressants in Men1. Joan Arehart-Treichel
Testosterone gel may produce antidepressant effects in men who are not responding to conventional medication.
When middle-aged men are depressed and antidepressants dont help them, there may be another effective treatment for themtestosterone.
Indeed, this is what Harrison Pope Jr., M.D., chief of the Biological Psychiatry Lab at McLean Hospital in Belmont, Mass., and coworkers found in a small, preliminary study. They reported their results in the January American Journal of Psychiatry.
These preliminary findings, they wrote, suggest that testosterone gel may produce antidepressant effects in the large and probably underrecognized population of depressed men with low testosterone levels.
Past studies have shown that some depressed men have low blood levels of testosterone. Men with underdeveloped testes often show depressive symptoms, and testosterone replacement may improve these symptoms. This tantalizing evidence, combined with the fairly recent availability of testosterone supplementation via a transdermal gel, prompted Pope and his coworkers to undertake an exploratory study. They wanted to see whether a testosterone gel might counter depression in men who hadnt gotten relief from antidepressants and who had testosterone levels on the low side for their age.
First Pope and his colleagues attempted to recruit, via radio ads and clinical referrals, potential subjects for their study. They were interested in men between 30 and 65 years of age who were experiencing a major depression and who were not receiving any relief from antidepressants. Fifty-six men expressed interest in participating in the investigation. Pope and his coworkers then tested each of the 56 men for morning blood levels of testosterone; 24 (43 percent) had borderline or low levels for their age (350 ng/dl or less).
Twenty-two of these men were then entered into the study, and they continued to take the same antidepressants that they had taken before. But in addition, 12 were randomized to receive 10 gms of a 1 percent testosterone gel daily for eight weeks, and the remaining 10 were randomized to receive a placebo gel daily for eight weeks. The researchers then tracked the subjects depression during the eight-week treatment period, using the Hamilton Depression Rating Scale, the Clinical Global Impression severity of illness scale, and the Beck Depression Inventory.
The subjects getting the testosterone gel improved, on average, significantly more than the subjects on a placebo, according to the Hamilton Depression Rating Scale. The improvement was evident on both the psychological aspects of depression, such as depressed mood, anxiety, or guilt, and on the somatic aspects of depression, such as sleep, appetite, and libido. The subjects getting the gel also showed, on average, a significantly greater rate of decrease in scores on the Clinical Global Impression severity of illness scale, but not on the Beck Depression Inventory.
Thus, it looks as if a testosterone gel might be able to help some depressed middle-aged men who receive no relief from antidepressants and who also have low levels of testosterone, Pope and his team concluded.
They also suspect that low testosterone levels may be unexpectedly common in middle-aged men with treatment-resistant depressive disorder since almost half of the 56 men who had been interested in participating in their study had borderline or low testosterone levels.
As far as negative side effects were concerned, one subject on testosterone reported difficulty urinating, suggesting that the testosterone was possibly exacerbating a case of benign prostatic hyperplasia. None of the other 11 subjects getting testosterone, however, reported any adverse effects. Thus, short-term treatment with testosterone gel appeared to produce minimally unfavorable effects.
This preliminary study, of course, did not answer some crucial questions, the researchers noted. For instance, what effect would testosterone supplementation over a longer period have on depression? Would it help depressed men not taking antidepressants, or would it be more useful as an adjunct to antidepressant treatment? Would giving testosterone over the long haul aggravate benign prostate hyperplasia or increase the risk of prostate cancer? And finally, how might testosterone counter depression? It is too early to speculate, Pope told Psychiatric News, because it is a very idiosyncratic response in that some of our subjects responded dramatically, whereas others had absolutely no effect.
Given the positive results from this preliminary study, however, and the potential public health benefits that might accrue from them, the value of testosterone as a depression treatment should definitely be explored, Pope and his team believe.
The study report, Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial, is posted on the Web at http://ajp.psychiatryonline.org/cgi/content/full/160/1/105. ▪ "
"Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression
Journal of Affective Disorders, Volume 48, Issue 2, Pages 157-161
S.Seidma
AbstractBackground: Testosterone replacement therapy is an effective treatment of some depressive symptoms in hypogonadal men, and may be an effective augmentation treatment for SSRI-refractory major depression in such men. Methods: We treated five depressed men who had low testosterone levels and had not responded to an adequate SSRI trial with 400 mg testosterone replacement biweekly for 8 weeks. Four patients underwent single-blind placebo discontinuation. Patients were assessed at baseline and biweekly thereafter using the Hamilton Depression Rating Scale (HAM-D) and the Endicott Quality of Life Enjoyment and Satisfaction Scale (Q-LES-Q). Results: Patients' mean age was 40 years, and mean testosterone level 277 ng/dl. All had a rapid and dramatic recovery from major depression following testosterone augmentation: mean 21-item HAM-D decreased from 19.2 to 7.2 by week 2, and to 4.0 by week 8; mean Q-LES-Q increased from 45% to 68%. Three of four subjects who underwent discontinuation of testosterone under single-blind placebo treatment began to relapse. Conclusion: Testosterone replacement therapy may be an effective treatment of depressive symptoms in some men, and warrants further research."
"Antidepressant-Induced Sexual Dysfunction Associated with Low Serum Free TestosteronePresented by Alan J. Cohen, M.D.,
Private Practice and Assistant Clinic Professor of Psychiatry, UCSFSUMMARY
In the course of an evaluation for treatment of antidepressant induced sexual dysfunction (ASD) with a new agent, an unforeseen pattern emerged in the pre-treatment laboratory assessment. Free serum testosterone levels in both men and women study subjects were found to be below the normal ranges in 75 percent of subjects in this small study. There were no other consistent laboratory findings that could account for such a high percentage correlation. Further inquiries into the possible causes for decreased serum testosterone and its association with ASD seems warranted."
Posted by JackFord on February 19, 2010, at 18:27:21
In reply to testosterone for male TRD, posted by Rosy Crucifiction on November 28, 2009, at 12:04:53
Very interesting post. Do you have experience with TRD and testosterone? I have TRD, and have tested three times with borderline low (<250) testosterone, but have had trouble getting a psychiatrist or endocrinologist to give me trial of testosterone.
Any thoughts - from you or anyone else - on this? Other references, experience?
Thanks again for a great post.
> For many, affecting neurotransmitters with antidepressants has had limited success, or results in only short term success with relapse. Clearly other physical systems can influence mood and may help relieve depression. Thyroid augmentation, for instance, has long been used as a depression treatment.
>
> The link in women between estrogen levels and depression has been known, and therapeutically relevant, for some time. Men with frank hypogonadism (clearly subclinical serum and free testosterone levels) are known to have high rates of depression. This can be readily resolved with testosterone replacement therapy. Interestingly, testosterone increase dopamine levels.
>
> In those with "normal" testosterone levels and TRD, it seems likely that testosterone replacement could offer an additional therapeutic option. Options include testosterone gels, implants, and injections as well as indirect boosting of testosterone levels with HCG and other compounds. There are few studies available, but anecdotal evidence among men receiving TRT is strong. Combining direct testosterone enhancement with HCG seems to have minimal long term effects on the HPTA axis.
>
> Concerns about side effects include prostate enlargement and estrogenic side effects. Both sets of side effects can be readily addressed by supplements or, in more severe cases, well known and fairly benign medications.
>
> Three relevant studies:
> "Testosterone May Boost Efficacy Of Antidepressants in Men
>
> 1. Joan Arehart-Treichel
>
> Testosterone gel may produce antidepressant effects in men who are not responding to conventional medication.
>
> When middle-aged men are depressed and antidepressants dont help them, there may be another effective treatment for themtestosterone.
>
> Indeed, this is what Harrison Pope Jr., M.D., chief of the Biological Psychiatry Lab at McLean Hospital in Belmont, Mass., and coworkers found in a small, preliminary study. They reported their results in the January American Journal of Psychiatry.
>
> These preliminary findings, they wrote, suggest that testosterone gel may produce antidepressant effects in the large and probably underrecognized population of depressed men with low testosterone levels.
>
> Past studies have shown that some depressed men have low blood levels of testosterone. Men with underdeveloped testes often show depressive symptoms, and testosterone replacement may improve these symptoms. This tantalizing evidence, combined with the fairly recent availability of testosterone supplementation via a transdermal gel, prompted Pope and his coworkers to undertake an exploratory study. They wanted to see whether a testosterone gel might counter depression in men who hadnt gotten relief from antidepressants and who had testosterone levels on the low side for their age.
>
> First Pope and his colleagues attempted to recruit, via radio ads and clinical referrals, potential subjects for their study. They were interested in men between 30 and 65 years of age who were experiencing a major depression and who were not receiving any relief from antidepressants. Fifty-six men expressed interest in participating in the investigation. Pope and his coworkers then tested each of the 56 men for morning blood levels of testosterone; 24 (43 percent) had borderline or low levels for their age (350 ng/dl or less).
>
> Twenty-two of these men were then entered into the study, and they continued to take the same antidepressants that they had taken before. But in addition, 12 were randomized to receive 10 gms of a 1 percent testosterone gel daily for eight weeks, and the remaining 10 were randomized to receive a placebo gel daily for eight weeks. The researchers then tracked the subjects depression during the eight-week treatment period, using the Hamilton Depression Rating Scale, the Clinical Global Impression severity of illness scale, and the Beck Depression Inventory.
>
> The subjects getting the testosterone gel improved, on average, significantly more than the subjects on a placebo, according to the Hamilton Depression Rating Scale. The improvement was evident on both the psychological aspects of depression, such as depressed mood, anxiety, or guilt, and on the somatic aspects of depression, such as sleep, appetite, and libido. The subjects getting the gel also showed, on average, a significantly greater rate of decrease in scores on the Clinical Global Impression severity of illness scale, but not on the Beck Depression Inventory.
>
> Thus, it looks as if a testosterone gel might be able to help some depressed middle-aged men who receive no relief from antidepressants and who also have low levels of testosterone, Pope and his team concluded.
>
> They also suspect that low testosterone levels may be unexpectedly common in middle-aged men with treatment-resistant depressive disorder since almost half of the 56 men who had been interested in participating in their study had borderline or low testosterone levels.
>
> As far as negative side effects were concerned, one subject on testosterone reported difficulty urinating, suggesting that the testosterone was possibly exacerbating a case of benign prostatic hyperplasia. None of the other 11 subjects getting testosterone, however, reported any adverse effects. Thus, short-term treatment with testosterone gel appeared to produce minimally unfavorable effects.
>
> This preliminary study, of course, did not answer some crucial questions, the researchers noted. For instance, what effect would testosterone supplementation over a longer period have on depression? Would it help depressed men not taking antidepressants, or would it be more useful as an adjunct to antidepressant treatment? Would giving testosterone over the long haul aggravate benign prostate hyperplasia or increase the risk of prostate cancer? And finally, how might testosterone counter depression? It is too early to speculate, Pope told Psychiatric News, because it is a very idiosyncratic response in that some of our subjects responded dramatically, whereas others had absolutely no effect.
>
> Given the positive results from this preliminary study, however, and the potential public health benefits that might accrue from them, the value of testosterone as a depression treatment should definitely be explored, Pope and his team believe.
>
> The study report, Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial, is posted on the Web at http://ajp.psychiatryonline.org/cgi/content/full/160/1/105. ▪ "
>
> "Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression
> Journal of Affective Disorders, Volume 48, Issue 2, Pages 157-161
> S.Seidma
> Abstract
>
> Background: Testosterone replacement therapy is an effective treatment of some depressive symptoms in hypogonadal men, and may be an effective augmentation treatment for SSRI-refractory major depression in such men. Methods: We treated five depressed men who had low testosterone levels and had not responded to an adequate SSRI trial with 400 mg testosterone replacement biweekly for 8 weeks. Four patients underwent single-blind placebo discontinuation. Patients were assessed at baseline and biweekly thereafter using the Hamilton Depression Rating Scale (HAM-D) and the Endicott Quality of Life Enjoyment and Satisfaction Scale (Q-LES-Q). Results: Patients' mean age was 40 years, and mean testosterone level 277 ng/dl. All had a rapid and dramatic recovery from major depression following testosterone augmentation: mean 21-item HAM-D decreased from 19.2 to 7.2 by week 2, and to 4.0 by week 8; mean Q-LES-Q increased from 45% to 68%. Three of four subjects who underwent discontinuation of testosterone under single-blind placebo treatment began to relapse. Conclusion: Testosterone replacement therapy may be an effective treatment of depressive symptoms in some men, and warrants further research."
>
>
> "Antidepressant-Induced Sexual Dysfunction Associated with Low Serum Free Testosterone
>
> Presented by Alan J. Cohen, M.D.,
> Private Practice and Assistant Clinic Professor of Psychiatry, UCSF
>
> SUMMARY
>
> In the course of an evaluation for treatment of antidepressant induced sexual dysfunction (ASD) with a new agent, an unforeseen pattern emerged in the pre-treatment laboratory assessment. Free serum testosterone levels in both men and women study subjects were found to be below the normal ranges in 75 percent of subjects in this small study. There were no other consistent laboratory findings that could account for such a high percentage correlation. Further inquiries into the possible causes for decreased serum testosterone and its association with ASD seems warranted."
>
Posted by Deneb on February 20, 2010, at 21:20:57
In reply to Re: testosterone for male TRD » Rosy Crucifiction, posted by JackFord on February 19, 2010, at 18:27:21
Hello JackFord!
Welcome to Psycho-Babble. I hope someone helps you out with your question. I'm a woman so I'm no help. LOL
Deneb
This is the end of the thread.
Psycho-Babble Neurotransmitters | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.